Skip to main content

WARN Act Layoffs in Bridgewater, New Jersey

WARN Act mass layoff and plant closure notices in Bridgewater, New Jersey, updated daily.

1
Notices (2026)
67
Workers Affected
Baker & Taylor
Biggest Filing (67)
Wholesale Trade
Top Industry

Latest WARN Notices in Bridgewater

WARN Act layoff notices
CompanyCityEmployeesNotice DateType
Baker & TaylorBridgewater67
PVHBridgewater51
PHVBridgewater59
SDH Services EastBridgewater54
QualcommBridgewater91
PvhBridgewater56
PvhBridgewater13
Christmas Tree Shops - Location 3Bridgewater40
Starplast USABridgewater23
Lord & Taylor - BridgewaterBridgewater55
Baker & TaylorBridgewater244
Futurewei TechnologiesBridgewater49
Baker & TaylorBridgewater244
Spectrum PharmaceuticalsBridgewater2
DSJ Holding, Inc. (f/k/a Bridgewater Wholesalers, Inc.)Bridgewater133
Eli LillyBridgewater78
AllerganBridgewater69
CareFusion ResourcesBridgewater390
sanofi-aventis U.SBridgewater391
HsbcBridgewater49

Analysis: Layoffs in Bridgewater, New Jersey

# Economic Analysis: Bridgewater's Layoff Landscape and Workforce Disruption

Overview: Scale and Significance

Bridgewater, New Jersey has experienced substantial workforce disruptions over the past two decades, with 31 Worker Adjustment and Retraining Notification (WARN) notices affecting 4,404 workers since 2004. While this figure may appear modest compared to major manufacturing hubs, it represents significant dislocation in a mid-sized municipality and signals recurring vulnerability in key employment sectors. The average layoff size per WARN notice in Bridgewater stands at 142 workers, indicating that while some events involve large-scale facility closures, the majority reflect moderate workforce reductions concentrated in specific industries and employers.

The temporal distribution of these layoffs reveals a municipality experiencing cyclical economic stress rather than terminal decline. The data shows clustering around economic downturns—three notices in 2004, three again in 2009 during the Great Recession, and a notable uptick to five notices in 2019 alongside pre-pandemic corporate restructuring. More recent activity in 2023 (four notices) and early 2025 (two notices) suggests ongoing sectoral contraction despite stronger macroeconomic conditions nationally. This pattern indicates that Bridgewater's layoff trajectory is driven less by generalized economic weakness than by company-specific strategic decisions and industry-level consolidation within the pharmaceutical, distribution, and technology sectors that anchor the local economy.

Pharmaceutical and Distribution Dominance: Key Employers and Structural Forces

Three employers account for nearly 1,683 workers across five WARN notices: Baker & Taylor, Ortho Biotech, and the paired Sanofi-Aventis entities. Baker & Taylor, a major book and media distributor, filed three separate notices affecting 555 workers, indicating prolonged restructuring rather than a single catastrophic closure. This pattern reflects the broader collapse of traditional book distribution networks facing Amazon's market dominance and the secular decline of physical media retail. The company's repeated need for workforce reductions across multiple years demonstrates the relentless pressure on legacy distribution models.

Ortho Biotech, a Johnson & Johnson subsidiary, and the Sanofi-Aventis complex—represented by two separate filings totaling 1,040 workers—anchor Bridgewater's position as a pharmaceutical manufacturing and development hub. Combined, these three entities (Baker & Taylor, Ortho Biotech, and Sanofi-Aventis) represent 1,683 of the 4,404 total workers affected, or roughly 38 percent of all Bridgewater WARN activity. The pharmaceutical sector filings reflect a pattern of industry-wide consolidation through mergers, manufacturing relocations to lower-cost jurisdictions, and shift toward outsourced contract manufacturing. Notably, Sanofi-Aventis U.S. filed separately from its parent entity, suggesting internal corporate restructuring and potential cost-allocation changes between subsidiary and holding company.

Supporting the pharmaceutical cluster, CareFusion Resources (390 workers) and Biovail Pharm (340 workers) added 730 workers to pharmaceutical-adjacent workforce reductions. Combined with Ortho Biotech and Sanofi-Aventis, the pharmaceutical and life sciences sector generated approximately 1,770 workers affected—just under 40 percent of Bridgewater's total WARN activity. The concentration of pharmaceutical layoffs reflects the sector's capital intensity, vulnerability to patent cliffs, and ongoing consolidation wave that has defined the industry since the early 2000s.

Home Depot, PNC Financial, and Qualcomm represent smaller but strategically important employers. Home Depot's single notice affecting 99 workers likely reflects store closures or distribution center rationalization during the retail real estate downturn. PNC Financial's 131-worker reduction aligns with broader banking sector cost-cutting and technology automation reducing back-office employment. Qualcomm's 91-worker notice signals potential semiconductor design or engineering role reductions, possibly reflecting outsourcing to lower-cost jurisdictions or consolidation following mergers within the tech sector.

Industry Structure: Manufacturing Crisis and Sectoral Vulnerability

Manufacturing dominates Bridgewater's WARN landscape, accounting for 14 notices affecting 2,465 workers—56 percent of all Bridgewater layoffs. This reflects the municipality's historical role as a manufacturing and distribution center serving the broader Northeast corridor. Information and Technology layoffs (5 notices, 743 workers) represent the second-largest category, driven by Qualcomm and smaller professional services firms. Wholesale Trade (4 notices, 688 workers) captures distribution sector vulnerability, with Baker & Taylor contributing substantially to this category.

The manufacturing concentration reveals structural headwinds unrelated to short-term economic cycles. Pharmaceutical manufacturing in particular has faced decades of pressure from patent expirations, generic competition, and FDA regulatory costs. The shift toward contract manufacturing organizations (CMOs) and manufacturing partnerships in lower-cost jurisdictions has hollowed out traditional pharmaceutical employment in the Northeast. Information Technology layoffs reflect broader industry dynamics including software engineering offshoring, consolidation following mergers, and automation replacing mid-level technical roles.

Wholesale Trade figures emphasize the existential crisis facing traditional distribution models. Baker & Taylor's three notices across multiple years exemplify how legacy retailers and distributors face persistent competitive pressure requiring repeated workforce adjustments rather than single-event restructurings. The rise of direct-to-consumer e-commerce and dropshipping models eliminates the need for traditional warehousing and distribution employment that once anchored regional economies like Bridgewater.

Retail layoffs (4 notices, 245 workers) and Finance & Insurance (2 notices, 180 workers) demonstrate how secular shifts cascade across multiple sectors. These are not cyclical downturns but structural transformations—retail consolidation and store closures driven by e-commerce, banking automation reducing teller and back-office positions, and insurance operations shifting to digital platforms and remote work arrangements.

Historical Trends: Fragmented Recovery and Persistent Vulnerability

Bridgewater's WARN notice distribution across 22 years reveals no clear secular trend toward recovery or decline, but rather episodic clustering around macroeconomic shocks and industry-specific disruptions. The three notices in 2004 and two in 2005 likely reflect the tail end of the early-2000s manufacturing downturn following the dot-com recession. The 2008-2009 cluster (two notices in 2008, three in 2009) precisely marks the Great Recession and financial crisis impact on pharmaceutical, banking, and manufacturing employment.

The gap between 2009 and 2019—a full decade with only three scattered notices—suggests recovery during the 2010-2018 expansion and expansion of tech employment. However, the 2019 spike to five notices preceded COVID-19, indicating that corporate restructuring pressure persisted even during tight labor markets and strong GDP growth. This pattern is crucial: it demonstrates that Bridgewater's layoffs are not primarily cyclical but structural. Companies laid off workers during economic expansion years because of industry-specific challenges (pharmaceutical consolidation, distribution sector disruption) rather than generalized recession.

The 2023 cluster of four notices and 2025's two notices, occurring despite New Jersey's 2.76 percent insured unemployment rate and a national 4.3 percent unemployment rate, reinforces this structural interpretation. Bridgewater employers are shedding workforce not because the labor market is weak but because their own competitive positions, industry structures, and strategic priorities demand consolidation. This distinction matters enormously for workforce development policy and local economic development strategy.

Local Economic Impact and Community Consequences

Four thousand four hundred and four workers affected across 31 notices since 2004 represents significant cumulative dislocation. Using conservative estimates of 1.5 dependent family members per affected worker yields approximately 6,600 individuals experiencing household income disruption. In a municipality with limited economic diversification, concentrated dependence on pharmaceuticals and distribution creates substantial vulnerability.

The pharmaceutical and life sciences concentration creates particular challenges because wages in these sectors exceed local average income levels. When Sanofi-Aventis laid off 689 workers or Ortho Biotech reduced by 549 workers, the municipality lost high-wage employment that typically cannot be directly replaced by retail, hospitality, or lower-wage service sector alternatives. Manufacturing workers in pharmaceutical plants frequently earn $50,000-$80,000 annually with benefits packages that support middle-class stability; distributed retail positions average $30,000-$40,000 without comparable benefits.

The tax revenue impact deserves explicit attention. A worker earning $70,000 annually contributes approximately $2,100 in local property tax (assuming 3 percent effective rate on home values), plus sales tax, parking fees, and other municipal revenue streams. The cumulative loss of 4,404 workers represents approximately $9.2 million in annual local property tax revenue erosion, assuming gradual employment replacement within the community occurs. If those workers relocate to other jurisdictions or remain unemployed for extended periods, permanent revenue loss materially impacts municipal service capacity.

School district employment and real estate values face secondary effects. Declining municipal revenues constrain education budgets and building maintenance. When professional-class workers exit the community, housing demand softens, depressing property values that feed back into tax base contraction. Bridgewater's local development authority faces headwinds from structural industry forces far beyond municipal control.

Regional Context and Comparative Position

New Jersey's current unemployment landscape (5.2 percent state rate, 2.76 percent insured unemployment rate as of April 2026) frames Bridgewater's disruptions within a regional labor market experiencing localized stress despite macro stability. The state's initial jobless claims of 12,781 represent a 62.1 percent increase over the preceding four-week trend, suggesting emerging labor market deterioration not yet reflected in official unemployment statistics. This week-to-week volatility indicates potential economic vulnerability beneath surface-level stability metrics.

Bridgewater's 31 WARN notices across 22 years average 1.4 notices annually, lower than New Jersey's largest municipalities but concentrated in high-wage sectors where displacement impact exceeds aggregate numbers. The state's H-1B employment patterns provide essential context: New Jersey employers sponsored 246,964 H-1B/LCA certifications from 18,986 unique employers, concentrating in computer programming ($66,553 average), systems analysis ($78,154 average), and software development roles. The top H-1B employers—Tata Consultancy Services, Infosys, IBM India Private, Cognizant—represent offshore-outsourcing models that directly compete with domestic technology employment that might otherwise locate in innovation-adjacent communities like Bridgewater.

This competitive dynamic manifests in Bridgewater's Information Technology layoffs (5 notices, 743 workers). The simultaneous growth of H-1B-dependent outsourcing firms and layoffs at domestic technology employers suggests a labor market bifurcation where high-skill technology work migrates toward contract firms and offshore centers while traditional corporate technology employment contracts. Qualcomm's 91-worker reduction likely reflects this broader pattern.

H-1B and Foreign Labor: Simultaneous Hiring and Displacement

The data does not identify specific H-1B hiring by the major Bridgewater WARN filers, but the broader New Jersey context illuminates structural displacement dynamics. The pharmaceutical companies dominating Bridgewater's WARN notices—Sanofi-Aventis, Ortho Biotech, Eli Lilly, King Pharmaceuticals, Allergan—operate within an industry where H-1B usage remains substantial but less dominant than in software and technology sectors. However, manufacturing engineering, quality assurance, and regulatory affairs roles at these companies frequently involve H-1B professionals, particularly from India and China.

The occupational concentration in New Jersey H-1B data—26,605 computer programmer petitions, 22,480 systems analyst petitions—indicates that foreign labor competition centers on the Information Technology sector where Bridgewater shows 743 workers affected across five notices. This suggests that even as Qualcomm and other tech employers laid off 91 and smaller numbers of workers, the broader ecosystem may have simultaneously recruited H-1B visa holders for specialized roles, creating a bifurcated labor market where certain skill categories experience surplus displacement coexisting with claimed labor shortages in specific technical domains.

The average H-1B salary of $96,757 across New Jersey exceeds manufacturing average wages but aligns with pharmaceutical R&D and regulatory roles. The salary range extending to $422,864,000 (likely data entry errors or executive classifications) suggests significant variation in H-1B compensation. When companies lay off 550+ workers while simultaneously maintaining or expanding H-1B recruitment, the policy implication is that displacement reflects skill mismatch or cost optimization rather than genuine labor unavailability.

Forward Indicators and Emerging Vulnerabilities

Recent SEC 8-K filings show 539 filings from 373 companies in the past 30 days, with only six containing Item 2.05 layoff/restructuring disclosures. This low layoff signal rate (1.1 percent of all 8-K filings) suggests that aggregate corporate restructuring may be below crisis levels nationally. However, the recent WARN-matched bankruptcy filings (QVC Rocky Mount and St. Lucie facilities in mid-April 2026) demonstrate that formal bankruptcy precedes or accompanies WARN notice filings, providing a leading indicator.

Chapter 11 bankruptcy filings matched to WARN companies (537 of 1,723 total filings in the past 90 days) indicate that approximately 31 percent of bankruptcy activity correlates with workforce reduction signaling. For Bridgewater specifically, monitoring bankruptcy filings from Baker & Taylor, Pharmaceutical manufacturers, or other major employers should trigger early warning protocols.

The national JOLTS data showing 1,721,000 layoffs and discharges in February 2026 against 6,882,000 open positions suggests that while aggregate job creation continues, specific sectors and regions face persistent disruption. New Jersey showing 167,000 job openings against statewide employment of approximately 3.8 million implies a 4.4 percent job opening rate, above the national 4.3 percent rate. Yet this aggregate openness masks severe sectoral mismatches: pharmaceutical manufacturing, traditional distribution, and legacy technology employment contract while healthcare, logistics tech, and business services expand.

Bridgewater's vulnerability derives from its position as a legacy manufacturing and distribution hub in an economy rapidly shifting toward digital, biotechnology, and professional services models. Future WARN activity will likely concentrate in remaining traditional manufacturers facing obsolescence pressure and distribution facilities competing against automated fulfillment centers. Conversely, pharmaceutical R&D and biotech innovation roles may expand, though typically requiring advanced degrees and competing for talent against Boston, San Francisco, and Research Triangle ecosystems offering superior quality-of-life amenities and ecosystem density.

The municipality's economic future depends on managed transitions from legacy sectors toward advanced manufacturing, pharmaceutical innovation, and technology-adjacent services—a transformation that requires deliberate workforce development, infrastructure investment, and corporate recruitment focused on growth sectors rather than reactive workforce assistance for inevitable legacy industry decline.

Latest New Jersey Layoff Reports